New Risk • Apr 19
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 45% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Shareholders have been substantially diluted in the past year (45% increase in shares outstanding). Market cap is less than US$10m (CA$5.34m market cap, or US$3.90m). Minor Risk Share price has been volatile over the past 3 months (17% average weekly change). Announcement • Apr 15
Terra Balcanica Resources Corp. announced that it has received CAD 0.43937 million in funding On April 14, 2026, Terra Balcanica Resources Corp. closed the transaction. Finders’ fees in the amount of CAD 12,950 were paid to arm’s length finders that located purchasers for the Offering. Additionally, 259,000 finders’ warrants were issued. Dr. Aleksandar Miškovic, Director and CEO of the Company (the “Insider”), purchased 300,000 Units as part of the Offering. Announcement • Mar 23
Terra Balcanica Resources Corp. announced that it expects to receive CAD 0.3 million in funding Terra Balcanica Resources Corp. announced a private placement to issue 6,000,000 units at an issue price of CAD 0.05 for gross proceed of CAD 300,000 on March 23, 2026. Each unit will be comprised of one common share in the capital of the company and a common share purchase warrant to purchase an additional one common share at an exercise price of CAD 0.10 per warrant share for a period of 24 months from the closing date of the private placement. The units will be offered by way of prospectus exemptions in Canada, in the United States pursuant to available exemptions from the registration requirements and in certain jurisdictions outside of Canada and the United States, as determined by the company. The securities are subject to a hold period of four months plus one day from the closing date. The expected closing date is April 3, 2026, subject to certain conditions, including any requisite approval of the Canadian Securities Exchange. In certain circumstances, the company may pay finder’s fees in cash and warrants on a portion of the private placement 
